Skip to main content

Brainstorm Cell Therapeutics Inc. - Common Stock (NQ: BCLI )

2.280 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
January 27, 2013
Form 8-K
Source: SEC/Edgar
January 07, 2013
Form 8-K
Source: SEC/Edgar
December 19, 2012
Form 8-K
Source: SEC/Edgar
December 11, 2012
Form 10-Q/A
Source: SEC/Edgar
August 28, 2012
Form 8-K/A
Source: SEC/Edgar
August 26, 2012
Form 8-K
Source: SEC/Edgar
August 06, 2012
Form 8-K/A
Source: SEC/Edgar
August 05, 2012
Form D
Source: SEC/Edgar
July 26, 2012
Form 8-K
Source: SEC/Edgar
July 22, 2012
Form 8-K
Source: SEC/Edgar
July 19, 2012
Form 424B1
Source: SEC/Edgar
July 18, 2012
Form EFFECT
Source: SEC/Edgar
July 12, 2012
Form S-1/A
Source: SEC/Edgar
July 09, 2012
Form S-8
Source: SEC/Edgar
July 04, 2012
Form 8-K
Source: SEC/Edgar
July 02, 2012
Form S-1/A
Source: SEC/Edgar
June 28, 2012
Form 8-K
Source: SEC/Edgar
June 13, 2012
Form 8-K
Source: SEC/Edgar
June 13, 2012
Form S-1/A
Source: SEC/Edgar
May 16, 2012
Form ARS
Source: SEC/Edgar
May 10, 2012
Form DEF 14A
Source: SEC/Edgar
May 06, 2012
Form S-1/A
Source: SEC/Edgar
March 21, 2012
Form 8-K
Source: SEC/Edgar
March 12, 2012
Form S-1
Source: SEC/Edgar
February 02, 2012
Form 8-K
Source: SEC/Edgar
January 17, 2012
Form 10-K/A
Source: SEC/Edgar
December 27, 2011
Form 8-K/A
Source: SEC/Edgar
November 15, 2011
Form 10-Q/A
Source: SEC/Edgar
September 06, 2011
Form 8-K
Source: SEC/Edgar
August 22, 2011
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.